glp-1 and lupus Drugs Show Benefits in Patients With Diabetes Lupus & Life: Heart Health,

In 2025 I wrote my book Weightless and now, in 2026 Im building WeightlessAI

Third, oral semaglutide (Wegovy pill, $149/mo at Walgreens) entered US distribution in late 2025, giving needle-averse patients a brand-name option for the first time

At this concentration, 0.25 mg requires drawing 10 units on your insulin syringe, an amount that is easy to measure accurately

Neurogastroenterology and Motility

In addition to their glycemic effects, DPP-4 inhibitors have the potential to decrease bone resorption, increase bone formation, and reduce the incidence of osteoporosis and fractures

Novel Indications Trials are underway to assess GLP-1 efficacy in areas such as sleep apnea, cardiovascular risk reduction, neurodegenerative diseases (e.g., Alzheimers, Parkinsons), and womens health conditions like PCOS